Scientists from Oxitech Ltd., a UK company, recently field-tested a novel solution for the control of the mosquito that carries Dengue fever, using genetically modified sterile mosquitoes. The authors discussed the results of the first field trial and their hopes for the future of this approach.
Speakers included:
Prof Paul Reiter, Professor of Medical Entomology, Institute Pasteur in Paris
Dr Luke Alphey, Chief Scientific Officer and Co-Founder, Oxitec Ltd.